Advertisement
Review Article| Volume 37, ISSUE 1, P139-151, March 2023

Considering Patient, Family, and Provider Goals and Expectations in a Rapidly Changing Clinical Context: A Framework for Antimicrobial Stewardship at the End of Life

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Infectious Disease Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Marra A.R.
        • Puig-Asensio M.
        • Balkenende E.
        • et al.
        Antibiotic use during end-of-life care: A systematic literature review and meta-analysis.
        Infect Control Hosp Epidemiol. 2021; 42: 523-529
        • Vitetta L.
        • Kenner D.
        • Sali A.
        Bacterial infections in terminally ill hospice patients.
        J Pain Symptom Manage. 2000; 20: 326-334
        • Pereira J.
        • Watanabe S.
        • Wolch G.
        A retrospective review of the frequency of infections and patterns of antibiotic utilization on a palliative care unit.
        J Pain Symptom Manage. 1998; 16: 374-381
        • Chen J.H.
        • Lamberg J.L.
        • Chen Y.C.
        • et al.
        Occurrence and treatment of suspected pneumonia in long-term care residents dying with advanced dementia.
        J Am Geriatr Soc. 2006; 54: 290-295
        • Macedo F.
        • Nunes C.
        • Ladeira K.
        • et al.
        Antimicrobial therapy in palliative care: an overview.
        Support Care Cancer. 2018; 26: 1361-1367
        • Baghban A.
        • Juthani-Mehta M.
        Antimicrobial Use at the End of Life.
        Infect Dis Clin North Am. 2017; 31: 639-647
        • Bentley D.W.
        • Bradley S.
        • High K.
        • Schoenbaum S.
        • Taler G.
        • Yoshikawa T.T.
        • Gerontological Society of America, Clinical Medicine Section;; Infectious Diseases Society of America;; Society for Healthcare Epidemiology of America
        • American Geriatrics Society
        Practice guideline for evaluation of fever and infection in long-term care facilities.
        Clin Infect Dis. 2000 Sep; 31: 640-653
        • Servid S.A.
        • Noble B.N.
        • Fromme E.K.
        • et al.
        Clinical Intentions of Antibiotics Prescribed Upon Discharge to Hospice Care.
        J Am Geriatr Soc. 2018; 66: 565-569
        • Gaw C.E.
        • Hamilton K.W.
        • Gerber J.S.
        • et al.
        Physician Perceptions Regarding Antimicrobial Use in End-of-Life Care.
        Infect Control Hosp Epidemiol. 2018; 39: 383-390
        • Barlam T.F.
        • Cosgrove S.E.
        • Abbo L.M.
        • et al.
        Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.
        Clin Infect Dis. 2016; 62: e51-e77
        • Datta R.
        • Topal J.
        • McManus D.
        • et al.
        Perspectives on antimicrobial use at the end of life among antibiotic stewardship programs: A survey of the Society for Healthcare Epidemiology of America Research Network.
        Infect Control Hosp Epidemiol. 2019; 40: 1074-1076
        • Wu J.H.C.
        • Langford B.J.
        • Daneman N.
        • et al.
        Antimicrobial Stewardship Programs in Long-Term Care Settings: A Meta-Analysis and Systematic Review.
        J Am Geriatr Soc. 2019; 67: 392-399
        • Mitchell S.L.
        • D’Agata E.M.C.
        • Hanson L.C.
        • et al.
        The Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer Disease and Other Dementias (TRAIN-AD): A Cluster Randomized Clinical Trial.
        JAMA Intern Med. 2021; 181: 1174-1182
        • Yao C.A.
        • Hsieh M.Y.
        • Chiu T.Y.
        • et al.
        Wishes of Patients With Terminal Cancer and Influencing Factors Toward the Use of Antibiotics in Taiwan.
        Am J Hosp Palliat Care. 2015; 32: 537-543
        • Datta R.
        • Zhu M.
        • Han L.
        • et al.
        Increased Length of Stay Associated With Antibiotic Use in Older Adults With Advanced Cancer Transitioned to Comfort Measures.
        Am J Hosp Palliat Care. 2020; 37: 27-33
        • Thompson A.J.
        • Silveira M.J.
        • Vitale C.A.
        • et al.
        Antimicrobial use at the end of life among hospitalized patients with advanced cancer.
        Am J Hosp Palliat Care. 2012; 29: 599-603
        • Merel S.E.
        • Meier C.A.
        • McKinney C.M.
        • et al.
        Antimicrobial Use in Patients on a Comfort Care Protocol: A Retrospective Cohort Study.
        J Palliat Med. 2016; 19: 1210-1214
        • Tagashira Y.
        • Kawahara K.
        • Takamatsu A.
        • et al.
        Antimicrobial prescribing in patients with advanced-stage illness in the antimicrobial stewardship era.
        Infect Control Hosp Epidemiol. 2018; 39: 1023-1029
        • Taverner J.
        • Ross L.
        • Bartlett C.
        • et al.
        Antimicrobial prescription in patients dying from chronic obstructive pulmonary disease.
        Intern Med J. 2019; 49: 66-73
        • Kates O.S.
        • Krantz E.M.
        • Lee J.
        • et al.
        Association of Physician Orders for Life-Sustaining Treatment With Inpatient Antimicrobial Use at End of Life in Patients With Cancer.
        Open Forum Infect Dis. 2021; 8: ofab361
        • Lantz T.L.
        • Noble B.N.
        • McPherson M.L.
        • et al.
        Frequency and Characteristics of Patients Prescribed Antibiotics on Admission to Hospice Care.
        J Palliat Med. 2022; 25: 584-590
        • Furuno J.P.
        • Noble B.N.
        • Horne K.N.
        • et al.
        Frequency of outpatient antibiotic prescription on discharge to hospice care.
        Antimicrob Agents Chemother. 2014; 58: 5473-5477
        • Albrecht J.S.
        • McGregor J.C.
        • Fromme E.K.
        • et al.
        A nationwide analysis of antibiotic use in hospice care in the final week of life.
        J Pain Symptom Manage. 2013; 46: 483-490
        • D’Agata E.
        • Mitchell S.L.
        Patterns of antimicrobial use among nursing home residents with advanced dementia.
        Arch Intern Med. 2008; 168: 357-362
        • Datta R.
        • Topal J.
        • McManus D.
        • et al.
        Education needed to improve antimicrobial use during end-of-life care of older adults with advanced cancer: A cross-sectional survey.
        Palliat Med. 2021; 35: 236-241
        • Rosenberg J.H.
        • Albrecht J.S.
        • Fromme E.K.
        • et al.
        Antimicrobial use for symptom management in patients receiving hospice and palliative care: a systematic review.
        J Palliat Med. 2013; 16: 1568-1574
        • Clark M.D.
        • Halford Z.
        • Herndon C.
        • et al.
        Evaluation of Antibiotic Initiation Tools in End-of-Life Care.
        Am J Hosp Palliat Care. 2022; 39: 274-281
        • White P.H.
        • Kuhlenschmidt H.L.
        • Vancura B.G.
        • et al.
        Antimicrobial use in patients with advanced cancer receiving hospice care.
        J Pain Symptom Manage. 2003; 25: 438-443
        • Reinbolt R.E.
        • Shenk A.M.
        • White P.H.
        • et al.
        Symptomatic treatment of infections in patients with advanced cancer receiving hospice care.
        J Pain Symptom Manage. 2005; 30: 175-182
        • Clayton J.
        • Fardell B.
        • Hutton-Potts J.
        • et al.
        Parenteral antibiotics in a palliative care unit: prospective analysis of current practice.
        Palliat Med. 2003; 17: 44-48
        • Givens J.L.
        • Jones R.N.
        • Shaffer M.L.
        • et al.
        Survival and comfort after treatment of pneumonia in advanced dementia.
        Arch Intern Med. 2010; 170: 1102-1107
        • Van Der Steen J.T.
        • Pasman H.R.W.
        • Ribbe M.W.
        • et al.
        Discomfort in dementia patients dying from pneumonia and its relief by antibiotics.
        Scand J Infect Dis. 2009; 41: 143-151
        • Oh D.Y.
        • Kim J.H.
        • Kim D.W.
        • et al.
        Antibiotic use during the last days of life in cancer patients.
        Eur J Cancer Care (Engl). 2006; 15: 74-79
        • Chen L.K.
        • Chou Y.C.
        • Hsu P.S.
        • et al.
        Antibiotic prescription for fever episodes in hospice patients.
        Support Care Cancer. 2002; 10: 538-541
        • Nakagawa S.
        • Toya Y.
        • Okamoto Y.
        • et al.
        Can anti-infective drugs improve the infection-related symptoms of patients with cancer during the terminal stages of their lives?.
        J Palliat Med. 2010; 13: 535-540
        • Chih A.H.
        • Lee L.T.
        • Cheng S.Y.
        • et al.
        Is it appropriate to withdraw antibiotics in terminal patients with cancer with infection?.
        J Palliat Med. 2013 Nov; 16: 1417-1422
        • Helde-Frankling M.
        • Bergqvist J.
        • Bergman P.
        • et al.
        Antibiotic Treatment in End-of-Life Cancer Patients-A Retrospective Observational Study at a Palliative Care Center in Sweden.
        Cancers (Basel). 2016; 8: E84
        • Morrison R.S.
        • Ahronheim J.C.
        • Morrison G.R.
        • et al.
        Pain and discomfort associated with common hospital procedures and experiences.
        J Pain Symptom Manage. 1998; 15: 91-101
        • Levin P.D.
        • Simor A.E.
        • Moses A.E.
        • et al.
        End-of-life treatment and bacterial antibiotic resistance: a potential association.
        Chest. 2010; 138: 588-594
        • Khandelwal N.
        • Benkeser D.
        • Coe N.B.
        • et al.
        Patterns of Cost for Patients Dying in the Intensive Care Unit and Implications for Cost Savings of Palliative Care Interventions.
        J Palliat Med. 2016; 19: 1171-1178
        • Angus D.C.
        • Barnato A.E.
        • Linde-Zwirble W.T.
        • et al.
        Use of intensive care at the end of life in the United States: an epidemiologic study.
        Crit Care Med. 2004; 32: 638-643
        • Brennan S.C.
        • Redd W.H.
        • Jacobsen P.B.
        • et al.
        Anxiety and panic during magnetic resonance scans.
        Lancet. 1988; 2: 512
        • Winokur R.S.
        • Pua B.B.
        • Sullivan B.W.
        • et al.
        Percutaneous lung biopsy: technique, efficacy, and complications.
        Semin Intervent Radiol. 2013; 30: 121-127
        • Paonessa J.R.
        • Shah R.D.
        • Pickens C.I.
        • et al.
        Rapid Detection of Methicillin-Resistant Staphylococcus aureus in BAL: A Pilot Randomized Controlled Trial.
        Chest. 2019; 155: 999-1007
        • Jones B.E.
        • Ying J.
        • Stevens V.
        • et al.
        Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia.
        JAMA Intern Med. 2020; 180: 552-560
        • Schuetz P.
        • Wirz Y.
        • Sager R.
        • et al.
        Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
        Cochrane Database Syst Rev. 2017; 10: CD007498
        • Fabre V.
        • Klein E.
        • Salinas A.B.
        • et al.
        A Diagnostic Stewardship Intervention To Improve Blood Culture Use among Adult Nonneutropenic Inpatients: the DISTRIBUTE Study.
        J Clin Microbiol. 2020; 58: e01053-e01120
        • Ford P.J.
        • Fraser T.G.
        • Davis M.P.
        • et al.
        Anti-infective therapy at the end of life: ethical decision-making in hospice-eligible patients.
        Bioethics. 2005; 19: 379-392
        • Vaughan L.
        • Duckett A.A.
        • Adler M.
        • et al.
        Ethical and Clinical Considerations in Treating Infections at the End of Life.
        J Hosp Palliat Nurs. 2019; 21: 110-115
        • Broom J.
        • Broom A.
        • Good P.
        • et al.
        Why is optimisation of antimicrobial use difficult at the end of life?.
        Intern Med J. 2019; 49: 269-271
        • Dryden M.
        • Johnson A.P.
        • Ashiru-Oredope D.
        • et al.
        Using antibiotics responsibly: right drug, right time, right dose, right duration.
        J Antimicrob Chemother. 2011; 66: 2441-2443
        • Givens J.L.
        • Spinella S.
        • Ankuda C.K.
        • et al.
        Healthcare Proxy Awareness of Suspected Infections in Nursing Home Residents with Advanced Dementia.
        J Am Geriatr Soc. 2015; 63: 1084-1090
        • Sinert M.
        • Stammet Schmidt M.M.
        • Lovell A.G.
        • et al.
        Guidance for Safe and Appropriate Use of Antibiotics in Hospice Using a Collaborative Decision Support Tool.
        J Hosp Palliat Nurs. 2020; 22: 276-282